NCT03451526View on ClinicalTrials.gov

A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

2,929

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

March 30, 2018

Conditions
Non-small Cell Lung Cancer
Interventions
PROCEDURE

Surgeries

Surgeries plus adjuvant chemotherapies or perioperative chemotherapies

Trial Locations (10)

100029

China-Japan Friendship Hospital, Beijing

100853

China PLA General Hospital, Beijing

200003

Shanghai Chest Hospital, Shanghai

210009

Jiangsu cancer hospital, Nanjing

300051

Tianjin Chest Hospital, Tianjin

310003

First Hospital Affiliated to Zhejiang University, Hangzhou

430030

Tongji Hospital Affiliated to Huazhong Technology Hospital, Wuhan

450008

Henan cancer hospital, Zhengzhou

610041

Huaxi Hospital Affiliated to Sichuan University, Chengdu

710000

Xi'an Tangdu Hospital, Xi'an

All Listed Sponsors
collaborator

LinkDoc Technology (Beijing) Co. Ltd.

INDUSTRY

lead

Tang-Du Hospital

OTHER

NCT03451526 - A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter